Kathryn Atkins, Author at Oncotarget

Novel Triple-Drug Combination to Fight Pancreatic Cancer

In this new study, researchers unveiled a promising synergistic strategy for combating pancreatic cancer.—In... read more

July 25, 2024

In this new study, researchers investigated an artificial intelligence (AI) tool that produces attenuation-corrected PET... read more

July 11, 2024

In this new study, researchers assessed the feasibility of treating HR+/HER2-negative breast cancer patients... read more

June 20, 2024

This article dissects Dr. Mikhail V. Blagosklonny’s paradigm-shifting perspective on preemptive combinations for treating... read more

June 6, 2024

In this new study, researchers examined the impact of MIA-602 as monotherapy and in combination... read more

May 23, 2024

In this new study, researchers investigated the interplay between the SARS-CoV-2 spike protein and tumor... read more

May 9, 2024

In this new study, researchers investigated a promising new approach to acute myeloid leukemia (AML)... read more

April 11, 2024

In this study, researchers investigated the antitumor effects of Sacituzumab govitecan in combination with platinum-based... read more

March 14, 2024

In this new study, researchers provide valuable insights into raw areca nut betel quid consumption... read more

February 22, 2024

Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month,... read more

February 15, 2024